In This Section


  • January 23, 2013

    Temple Scientists Find Cervical Cancer-Causing Virus In The Brain, Show Potential Connection To Epilepsy

    Researchers at Shriners Hospitals Pediatric Research Center at the Temple University School of Medicine and the University of Pennsylvania have evidence linking the human papillomavirus 16 (HPV16) – the most common cause of cervical cancer – to a common form of childhood epilepsy.

  • January 17, 2013

    Temple Researchers Testing Miniature Lung Coils as a Novel Treatment For Emphysema

    Temple researchers are testing whether implanting miniature coils in the airways of diseased lungs can improve breathing, activity levels and quality of life for emphysema patients.

    The coils work by compressing damaged tissue, which allows the healthier parts of the lung to function more efficiently and make breathing easier. The coils are made of Nitinol, a metal commonly used in medical implants, and offer a minimally invasive alternative to lung volume reduction surgery.

  • August 20, 2012

    Temple Scientist Awarded Grants for Lung, Brain Injury Studies

    A researcher at Temple University School of Medicine has been awarded a pair of grants totaling nearly $4.5 million from the Office of Naval Research (ONR) to study the use and effectiveness of a type of chemical in helping protect the lungs of soldiers and other military personnel from the effects of high altitude. In a separate project, she plans to examine the chemical’s usefulness in lessening the impact of traumatic brain injuries.

  • August 17, 2012

    Temple Researchers Receive $11.6 Million to Study Ways to Reduce Heart Attack Damage

    Scientists at Temple University School of Medicine have been awarded a five-year, $11.6 million grant from the National Heart, Lung and Blood Institute of the National Institutes of Health to develop new approaches to prevent, slow or reverse damage to the heart after a heart attack.

  • July 23, 2012

    Temple University Hospital Offers Landmark Stem Cell Trial for Heart Disease

    Temple University Hospital is participating in a Phase-3, nationwide clinical trial for patients with ischemic heart disease. Temple is the only hospital in the Philadelphia region to study this promising treatment.

    The trial – called RENEW – is investigating whether a patient’s own stem cells can help reduce angina and improve blood flow to the heart by creating new blood vessels. 

  • June 27, 2012

    Dr. Susan Wiegers Joins Temple as Senior Associate Dean of Faculty Affairs and Professor of Medicine

    Nationally recognized cardiologist Susan E. Wiegers, MD, has joined Temple University School of Medicine as Senior Associate Dean of Faculty Affairs and Professor of Medicine. She served previously as Director of Clinical Echocardiography at the Hospital of the University of Pennsylvania.

  • April 02, 2012

    Temple Researchers Show Promising Results with New Epigenetic Drug for Leukemia, Myelodysplastic Syndromes

    Promising results from an early stage, multicenter clinical trial led by researchers at Temple University School of Medicine have shown that a novel drug that alters the behavior of cancer cells may help patients with leukemia, as well as those with potentially dangerous blood disorders that frequently lead to leukemia. The findings, while preliminary, could lead to a new approach to treat various forms of cancer using a type of drug called a methylation inhibitor that seeks to modify changes to DNA that lead to cancer.